SPC Global Holdings Ltd (SPG) Earnings Call Transcript
August 28, 2026
Earnings Call Speaker Segments
These are our Full Year Results for FY '26. It's my pleasure to welcome SPC's CEO and Managing Director, Robert Iervasi, along with Brant Clutterbuck, our CFO. Just before we begin, please note that this webinar is being recorded. <<operator_script>> We've also gotten some questions ahead of today's call. We'll do our best to address as many of your questions as we can within the time available, and we may group together similar ones. Later today, the webinar will be posted on our Investor Center. Robert, over to you.
Thank you, and good morning, and we appreciate our shareholders being with us today for the FY '26 results. Today, we're going to walk you through SPC Global's full year results and the progress achieved in constructing a stronger, more credible platform for sustained growth. FY '26 is our first full financial year as a merged group, and that year was characterized by disciplined execution, improving earnings quality, strengthening the balance sheet and sharpening the platform for future growth, and we're excited to be sharing those details with you today. Of course, I'll let the disclaimer speak for itself. I simply note that today's presentation includes some forward-looking statements and investors and shareholders should read those statements in the context of the assumptions, risks, qualifications, et cetera, as set out in our presentation materials. And here, noting that we suggest you view today's presentation along with our formal ASX announcement and annual report, which will provide you with a more fulsome view of the FY '26 outcome, the basis of comparison and the strategic and operating context behind the numbers we'll talk about today. Now as has been mentioned, I'm joined today by Brant Clutterbuck, our Group Chief Financial Officer.
I'll start things off by walking through how the year went and the strategic headway we achieved right across the group. After that I'll pass things to Brant, who'll walk you through the financials in greater depth, and then we'll move on to the outlook and take your questions. So there are 4 main sections to what we're presenting today. The first is the business overview. The second covers how the strategy became action — tangible action — during FY '26. Third is a look at the FY '26 financial results. And last comes our outlook for FY '27 and beyond. What I hope comes through as the central takeaway is that FY '26 was a year of shifting away from an integration mindset toward performance, and of laying a sturdier foundation for growth in FY '27 and beyond. So let me kick off our sessions by reminding everyone what SPC Global looks like today. We now run as a food, beverage and dairy group that is more diversified, with a wider set of opportunities both at home and abroad than the legacy businesses had when each stood alone. When I think about what SPC Global is today, it's a market-leading Australian food, beverage and dairy business spanning 3 operating categories: food, beverages and dairy.
The group came into being via the merger and relisting in December 2024, uniting SPC, The Original Beverage Co—which is what it's called today—Nature One and Natural Ingredients beneath a single listed structure. As I said earlier, FY '26 is the first complete year in which we operate as that combined group. We employ roughly 800 people, carry about 1,000 products and, crucially, are present in 15 markets, supported by sovereign Australian manufacturing capability plus a portfolio spanning both staple resilient products and high-growth wellness and nutrition exposure. A defining characteristic of SPC Global is that we're simply — we are no longer merely a domestic pantry staples business. We now hold a meaningful international footprint spanning North Asia, Southeast Asia, the Middle East and North America, with live market presence in 15 markets and a growing export pathway for our privileged Australian-made products. During and after FY '26, we secured important ranging and launch milestones, among them Costco Japan for our OJC Black Label offering, E-Mart Traders in South Korea, Cold Storage in Singapore and Nature One's very own hypoallergenic and specialized infant formula range in China, once again delivering on those commitments we've made to the market about our global execution strategy. Which brings me to our investment thesis, and it's straightforward and evolving.
To start, we have strong underpinnings across a diversified portfolio that covers staples, beverages, wellness, and specialized nutrition. Second, we're enhancing the caliber of our growth via product mix, disciplined pricing, rigorous control of trade spend, and efficiencies in the supply chain, where our scale and size have been leveraged to generate concrete advantages for the organization. Third, international continues to be a high-margin growth engine, especially via Nature One and premium Australian brands across Asia Pacific. And fourth, the FY '26 equity raise substantially bolstered the balance sheet, so the group is better capitalized to pursue disciplined growth. Now shifting to execution. As I noted earlier, FY '26 was the year when the strategic rationale behind the merger started to become more evident in the numbers, in how the business operates day to day, and in what you could observe as a consumer either domestically or internationally. Both at home and abroad, the emphasis remained on profitable growth, margin quality, delivering synergies, and a more disciplined operating model. Let's begin with the domestic business. That domestic operation is still the group's anchor, delivering 59% of FY '26 group EBITDA, and it is increasingly managed with a value over volume mindset.
As we've said before, we've intentionally scaled back private label volumes that yield lower returns, sharpened our approach to promotions, grown the branded mix, and sped up beverages and on-the-go as a channel that works as a scalable, high-margin platform. That aligns with the wider discussion you'll see in our annual report and in our ASX release. Domestically, we're shifting from optimization toward acceleration led by the platform, with a keener emphasis on beverages as a category, on-the-go as a channel, and value optimization of brand and mix across our mainstream brands — SPC, Goulburn Valley and ProVital. Now we move to the significant international growth. That growth platform, or engine, accounted for roughly 41% of group EBITDA in FY '26 even though its revenue share is smaller. The strategic priority there is plain, and premiumization is at its core. Specialized proteins, branded dairy and nutrition, functional beverages, and premium food products that deliver structurally stronger margins than generic export contracts of low value. In FY '26, that strategy — which I've just laid out and which we've previously discussed with the market — has produced stronger EBITDA, improved gross margins and encouraging proof points in Japan, Korea, Singapore and China, while also setting a medium-term export ambition of approximately $37 million across the coming 3 years through various growth initiatives.
I'm glad you can see that what we laid out — what we do at home and abroad — has actually been carried out. And that's visible across our FY '26 results, not just in today's presentation but in all the supporting materials I mentioned earlier. Moving to the next slide, I'd also like to walk you through some highlights showing how broadly we executed during the year. As I said, we finished the $100 million equity raise. We've delivered $20 million in synergies since the merger. We've strengthened the Board and leadership and, with the Board's full backing, signed off on our 2026 to 2030 midterm plan, which really maps out our growth horizons over the coming medium term. We've locked in new ranging wins domestically and internationally, pushed forward new product launches and kept up the operational integration work, including the Mill Park transition and the Shepparton capability uplift. The thread running through all of this is that these weren't standalone moves. They were linked steps aimed at sharper strategic coherence, reduced risk, a more diversified portfolio and earnings base, and better quality in the earnings we'll generate going forward. I'll now pass to Brant, who will take you through the financial results in far more detail.
The key takeaway is that in FY '26 the group produced a substantially stronger earnings outcome, and at the same time it has reset the balance sheet and enhanced the business's underlying quality. I'm glad that Brant is now able to walk you through the way that has been brought to life financially.
Thanks, Robert. Before I get into the figures, I want to walk through one change — a change coming soon to how we report our segments. To give a clearer picture of the business's continuing operations, we'll be moving to reporting across 3 separate segments: Food, Beverages and Dairy. Alongside 2 geographic segments, we'll keep our focus on domestic and international operations. You'll notice this a bit during today's presentation and in the supporting materials. But keep in mind that this year is transitional, and our statutory accounts still reflect the 4 original business units: SPC, the Original Juice Company, Nature One Dairy and Natural Ingredients. So let's get into the figures. FY '26 net sales revenue came in at $331.8 million, with normalized EBITDA of $38.5 million. Domestic EBITDA accounted for $22.8 million, and international EBITDA was $15.7 million. Other headline numbers include net debt, which is down to $85.8 million after the successful capital raising in May 2026, bringing our net leverage to roughly 2x, and we delivered an inventory result of $129.3 million, which was favorable against the guidance we set of $130 million. Importantly, we keep capturing our synergy benefits. And as Robert mentioned earlier, $20 million of synergistic benefits have been delivered since the merger took place.
Looking at this slide from a divisional standpoint, it simply shows how varied our portfolio is. The SPC Group is still the biggest contributor to group net sales revenue, at roughly 69%, whereas EBITDA contribution is spread more evenly across the SPC Group, the Nature One business and The Original Beverage Company. That speaks to the quality of profit and to our international and beverage assets, which kept building momentum right through FY '26. Having this diversified earnings mix matters strategically, since it provides us with resilience as well as access to several growth levers. On the profit and loss side, net sales revenue once more came in at $331.8 million, below our FY '25 pro forma revenue figure of $376 million. That drop was intentional and mirrors the exit from lower-margin, lower-quality revenue that we have already talked about with the market. On a pleasing note, though, gross profit rose to 31.9% from 28.8%. Normalized EBITDA climbed to $38.5 million, up from $30.3 million delivered in FY '25. That means our EBITDA margin improved, going from 8.1% to 11.6%, or 3.5 basis points (sic) 3.5 percentage points. Put differently, we gave up some top line volume in exchange for materially better earnings quality. This aligns with the demand-led, margin-focused model we set out in our results release and in the annual report as well.
Domestic is the best illustration of that trade-off. Net sales at home fell to $287.7 million from $325.4 million, because we removed volume tied to lower returns. Even so, Domestic normalized EBITDA rose to $22.8 million from $16.7 million, helped by better margin, the effects of range rationalization, tighter promotional spend and a higher branded mix. That's precisely the kind of portfolio and channel discipline we set out to build into FY '26, and it will carry on in the years ahead. International turned in a high-quality result. Net sales revenue there did decline, to $45.9 million from $50.8 million, but that again mirrors our shift away from lower-margin contracts. Normalized EBITDA, though, went up to $15.7 million in FY '26 from $13.6 million in FY '25, and as a result the EBITDA margin climbed materially, to 34.2% from 26.8%. International saw very strong second-half results, especially in the last quarter, led by Nature One and by growing beverage momentum across Asia, which shows us the premiumization strategy is taking effect and working. Normalizations. Total normalization adjustments came to $16.7 million in FY '26. That was made up of redundancy costs, integration costs and costs tied to clearing excess inventory. Importantly, though, the cash impact of this was $6.7 million in FY '26.
The actual cash impact is much less than the $16.7 million figure that grabs the headlines. What we're seeing here fits with a business that's still integrating, reorganizing and rationalizing its product range after the transformational merger we recently completed. Our balance sheet ended the year a lot stronger. Cash rose to $48.9 million. Total equity climbed to $157.2 million, while net debt fell to $85.8 million, down from $123.7 million at the close of FY '25. The key factors behind that were the successful capital raise, which reset the balance sheet, repayment of borrowings, and ongoing discipline on working capital — together these substantially lifted liquidity and cut our financial risk. On inventory, as I said earlier, we finished at $129.3 million, which came in better than the $130 million guidance we gave the market and marked a big year-on-year drop from the $136.4 million at which FY '25 closed. We do note that the rise from December reflects the usual seasonality in our production cycle, yet the wider direction is still clearly downward, and we expect roughly $122 million by the close of FY '27. That's a meaningful signal of tighter working capital management and a better match between what we produce and what customers demand. Turning to cash flow: cash at 30 June stood at $48.9 million, and the year-on-year gain came mainly from net proceeds of the capital raise.
Cash coming in from financing was greater than the cash that went out for operations and investments. And measured on a free cash flow basis, prior to changes in working capital, we saw an $18.8 million gain compared with a year earlier. Now the next stage is to turn the higher EBITDA base and reduced debt expenses into consistently positive free cash flow. With that, I'll return the call to Robert.
Thank you, Brant, for that summary. As a management team—and you'd have seen this in today's results—we do get asked about what has changed when it comes to driving sustainable value for our business. What's different in what we're doing now compared with what we've done in the past? To understand this better, it's important to look at the SPC stand-alone business before the merger. This slide gives historical context and shows why FY '26 matters. Legacy SPC went through a period of weak cash conversion. In fact, at an operating cash flow level, both EBITDA cash conversion and free cash flow have been largely negative every year, which means the legacy business was spending more than it brought in. As you can see from the chart presented on the screen, this led to rising debt and, despite the negative cash position, inventory build, with inventory growing at a rate disproportionate to revenue. That placed a significant burden on Legacy SPC. Since the merger and throughout FY '26, the merged group has spent time resetting that trajectory through a demand-led operation, contract exits, working capital discipline and deleveraging. And as you can see, the merged group, which is larger in size than SPC stand-alone, holds less inventory than historical practices, despite our forecast of revenue growth.
This is a far more durable position for us. And what that means is the business comes into FY '27 standing on a sturdier base, with explicit guidance of revenue growth above 10%, EBITDA growth above 20% and — crucially — positive free cash flow. That's the standard shareholders ought to be able to count on from a business model that lasts. Let me now spend a little more time on the outlook. The Board and management see FY '27 as a pivotal year for conversion. The efforts made during FY '26 have strengthened the platform. What FY '27 involves is turning that platform into earnings, cash flow and market credibility that are more visible. I said earlier that our Board gave its endorsement to the midterm plan. That midterm plan rests on a clear mission. The mission is to reimagine nourishment and wellness for consumers globally. Our strategic pillars cover brands and products, channels and customers, supply chain and operations, responsibility and our people. The point that counts for our investors is that this isn't some abstract strategy document sitting in a drawer. It is a practical operating blueprint that ties the brand growth we discussed earlier to channel expansion, manufacturing efficiency, debt reduction, governance and capability building, all within a single coherent plan.
That gives us our market guidance for FY '27. Over the course of this financial year, we're aiming for a net sales revenue increase of more than 10% in both our domestic and international markets. We're also targeting EBITDA growth above 20%, measured against the FY '26 normalized EBITDA that Brant mentioned today. And we intend to deliver positive free cash flow, backed by a renewed, reinvigorated discipline around working capital and a strengthened balance sheet. Those targets are underpinned by the full year benefit of synergy initiatives, completion of the Mill Park transition we've previously discussed with the market, the Shepparton capability uplift, and further inventory discipline. Naturally, that also comes with lower debt costs following the equity raise, along with continued expansion in domestic beverages, on-the-go channels, and our international premium route to market. That wraps up the formal presentation from Brant and me, and we note there are additional slides offering more detail on half-on-half trends, inventory, leverage, and historical performance — which also supports what we've said on margin improvement, EBITDA growth, and the momentum we built in FY '26, particularly in the second half, and how that carries into FY '27.
With that said, I'll turn things back over to you, Fin, so you can begin taking questions from today's participants.
Thanks, Robert. <<operator_script>> So for the first question: as a shareholder, what I'd like to get a better understanding of is whether the Mill Park closure and transition are still fully on schedule to wrap up in October. What are the main execution risks that remain? And how confident is management that the roughly $8 million FY '27 EBITDA benefit that's expected will be recognized in full?
I can take that one, Fin. Thanks for asking about the Mill Park transition. We're happy to say that the Mill Park transition is still on schedule to wrap up in October of this financial year. Commissioning and shifting our Juice Lab shot lines into Shepparton is already in progress, and we're also building out the commissioning of the co-packing setup in Griffith, with the team collaborating alongside our co-packing partner to move volume before that October go-live. On the financial benefits side, we continue to be confident that $8 million of bankable EBITDA will be delivered in FY '27. As we've told the market before, the annualized figure will come in at approximately $11 million, or more than $11 million, and that benefit is on a like-for-like basis. This isn't meant to suggest it depends on growth in our beverages portfolio to generate that cost benefit to EBITDA. It's based on like-for-like volume. So the project remains on track, meaning the $8 million is on track for FY '27 and an annualized figure of greater than $11 million as a result.
Great, thanks. Next question: after the equity raise and the drop in net debt — how is management doing against the goal of bringing net leverage down to 1x to 1.2x by the close of FY '27? What are the main drivers behind that decrease — sorry, the principal drivers? And are there any factors we can foresee that might push it back?
Absolutely, Rob, I'll handle that question. Thanks once more. So net debt at the close of FY '26 has clearly come down to $85.8 million, a substantial step forward versus where we stood in FY '25, and that brings our net leverage ratio to roughly the 2x level. Our goal is to bring it to between 1 and 1.2x by the conclusion of FY '27. The main bridge toward that, I'd say, is plainly carrying out the strategies underpinning the business and meeting the outlook we've just shared with the market. That covers keeping up delivery of the synergy program, moving forward positively with the Mill Park transition so those $8 million of benefits land in year, and also getting the most return possible from automation productivity efficiencies throughout our wider footprint. Lower debt levels, clearly, are a relief where interest is concerned, and that definitely underpins the free cash flow position we're aiming for ahead. So we're very much concentrated on execution as we head into FY '27 to make sure we reach those targets.
Thank you. Let's go to the next question. A number of questions have come in about the share price. Even though EBITDA, margins and the balance sheet have improved, the share price has been underperforming. From management's point of view, what has to be shown during FY '27 for investors to feel more confident that the turnaround can be sustained and that the business holds value?
Sure, I'll take that question. Thank you for asking about the share price. We also recognize that, from where we sit, the share price isn't meeting expectations. Obviously, the most effective action management can take is to meet the commitments we've made to the market and show best-in-class execution of our strategy. Over the past 18 to 24 months, as the merger came together and we were able to relist on the stock exchange, management has met every commitment and guidance we've given to the market, and we expect that to keep going in FY '27 and beyond. So for us, giving greater confidence to our investors and the broader investment community means making sure we deliver on that strategy through execution excellence, meeting our commitments, and ensuring the disciplines we've discussed today stay in practice. Not just from a growth standpoint and in margin and EBITDA results, but the disciplines we've brought in around balance sheet management, debt management practices, and working capital all produce a balanced scorecard that, in my view, makes our business a very investment-worthy one listed on the Australian Stock Exchange.
Thank you. Moving on to the next question: across both the domestic and international sides of the business, where does management expect the biggest and most rewarding growth opportunities to lie over the coming 12 to 24 months? Specifically, how will resources be prioritized among beverages, on-the-go, branded food, specialized dairy, and the expanding export platform?
That's a great question, and it ties directly into the midterm plan strategy we discussed earlier—the one where beverages are treated as a category, on-the-go as an expansion channel, and our international business as well. Let me highlight a few data points that I believe are quite relevant to answering it. Looking at the FY '26 results and some of the figures that emerge from them, our beverages net sales revenue rose roughly 11.5%, 11.7% year-on-year in quarter 4, and that was driven by better distribution, new formats, channel momentum in on-the-go, and our focus on higher-margin products. So we began building momentum in quarter 3. That carried through into greater momentum in quarter 4, and we expect it to come to fruition in FY '27. In the domestic business, that's tied to widening distribution, growing on-the-go—petrol and convenience, for example—rolling out targeted formats, and the functional wellness-led innovation that consumers are excited about, that they want brought to life and delivered on a daily basis. We've had ranging—incremental ranging in Ampol, distribution through Amazon and Costco Australia, new bag-in-box formats for foodservice and catering, and we're continuing our expansion.
When it comes to how we're prioritizing the domestic business, what you'll see is that we're putting resources in — and not just resources, but also our innovation pipeline — behind those key growth categories and in the channels where doing so makes sense. And importantly, you may have seen in some of the materials we issued today that we recently combined our commercial operations and our supply chain operations in the domestic business under a single umbrella. The real purpose there is to drive end-to-end accountability across our domestic operations, making sure we're meeting the needs of our customers and consumers, and aligning it with the way we manage our international business. So that's one more example of how we've built a fit-for-purpose resource allocation model to deliver on that expectation. I'll touch on international very quickly. As I mentioned before, we have a presence in 15 markets across 5 regions, and the focus really is on our Australian-made portfolio in those markets. Strengths include the premium Australian-made nature of our product, Nature One's nutritional capability, product information, and expanding our portfolio across top-tier retailers in Japan, Korea, Singapore, and that list continues to grow. China always represents a strategically important market for us in our Nature One business division, particularly for our branded hypoallergenic and specialized infant formula product.
Development of a planned GoKids range launch in the health and wellness channel is still ongoing. So internationally, we keep concentrating on chasing opportunities via distributors and retail partnerships, with disciplined market development. We're aiming to tackle expansion of our beverages portfolio on the international stage. We've lately backed the shift of an extended shelf life production line from Mill Park to Shepparton so we can meet growing demand for our juice product abroad. And we've put more investment into additional salespeople on the ground in those international markets, making sure we deliver the reach our products can potentially achieve. So within the international business, you'll see us putting money into people on the ground, building the right capability in the right channel, and making sure our Australian manufacturing footprint can satisfy the demand we're seeing come through our international portfolio.
Great, thanks. The next question concerns the FY '27 outlook, which incorporates positive free cash flow. As a shareholder, I'd appreciate more clarity on how that will be reached. Which key improvements in operating cash flow and working capital do you expect over the year? And what should investors keep an eye on to gauge progress?
That one seems aimed at me. Thank you, Fin. So my answer is probably fairly similar to what I just discussed regarding lowering debt and our overall net leverage position through FY '27. On the operating cash flow side, beyond the reduced — synergy gains we are seeing come through from assets such as Mill Park and others, which bring operating cash flow benefits, I believe it is the ongoing discipline in working capital management that shareholders ought to keep watching from where we sit. I think we have shown some quite strong progress in the way we handle inventory levels throughout our seasonal cycle, landing under the $130 million target we set at the close of FY '26, which was very pleasing, but we should also track toward that $122 million closing figure for consolidated inventory near the end of FY '27, which helps release some positive operating cash flow back into the business as well. We have not been hesitant in discussions about cash conversion to EBITDA being a genuine priority for the management team right across SPC Global. So we are certainly working to make sure that this focus stays in place and that discipline carries on through FY '27.
Appreciate it. Moving on, the following question concerns FY '26 EBITDA, which took in synergies, better margins, and a move away from revenue with weaker returns. Would management walk us through what drives the FY '27 EBITDA growth target and say how much should come from recurring operations, Mill Park savings, additional synergies, and organic growth?
Absolutely. I may struggle a bit with that at a fairly high level. And first, I'll note that today we've given guidance that you should expect to see normalized FY '26 EBITDA growth of more than 20% in FY '27, and both management and the Board are confident in giving that guidance to the market, and our plans are consistent with achieving that outcome, and we look forward to updating the market over the course of the year on how we're tracking against the initiatives that deliver that outcome for us. It is fair to say that FY '26 included a number of very exciting initiatives, some of which carry into FY '27. And the capital raise itself gave us the opportunity to be able to fund some of those exciting initiatives that allow us to talk about that EBITDA uplift in FY '27. So what can we kind of share with you about what that makeup will look like? I've already spoken about Mill Park savings, and that's on track to deliver $8 million in FY '27, which is annualized greater than $11 million. As for some further synergies, we have introduced automation at our Auburn site, which is our frozen meals business, and that automation will deliver greater than $2 million of savings in FY '27.
We've made the operating model stronger and built up capability at our Shepparton site, and we've talked to the market before about some of the cost benefits that come from strengthening the capability and leadership model at that Shepparton factory — and from a synergistic standpoint, that's going to deliver roughly $4 million in benefits. And we do have the annualized run rate of other benefits that are flowing through. So the reason I share that with you is that most of the EBITDA uplift in FY '27 comes from projects that are either already implemented or close to being concluded, and largely within our control. On organic growth, that also contributes to EBITDA, but we aren't overly reliant, or materially reliant, on that organic growth to deliver the uplift. Our guidance is that we'll deliver 10% growth in top line, which is on track to be achieved in FY '27. So I hope investors leave the call today feeling confident in the guidance we're providing to the market.
Thank you. That brings the Q&A portion to a close. Robert, I'll hand things over to you for the closing remarks.
Thanks very much. Appreciate it, Fin, and thanks to all of you for being on today's call. To sum up, my perspective is that FY '26 was the year SPC Global shifted out of merger integration and into performance and execution. As I hope you've seen today, we've enhanced the quality of earnings, made the balance sheet stronger, pushed forward the strategic and operational integration of the group, and come into FY '27 with clearer priorities, a stronger financial foundation, and a focus on turning that platform into growth, positive cash flow, and shareholder value. And we truly do appreciate the support our shareholders have given us, and we look forward to keeping our shareholders updated on our progress over the course of the year. So thank you, everyone, and thank you, Fin, for moderating today.
Appreciate it, everybody.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete SPC Global Holdings Ltd transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.
Get an API key View API docs →For developers and AI pipelines
Programmatic access to SPC Global Holdings Ltd earnings transcripts and 132,000+ others is available through the
EarningsAPI REST API and the hosted MCP server.
Quarterly plans from $162 - full transcripts, speaker segments, full-text search,
and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.